These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Compound heterozygous mutations in the Liu M; Xia JL; Yang H; Yu L Ophthalmic Genet; 2022 Aug; 43(4):538-542. PubMed ID: 35291925 [TBL] [Abstract][Full Text] [Related]
30. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Vithana EN; Morgan PE; Ramprasad V; Tan DT; Yong VH; Venkataraman D; Venkatraman A; Yam GH; Nagasamy S; Law RW; Rajagopal R; Pang CP; Kumaramanickevel G; Casey JR; Aung T Hum Mol Genet; 2008 Mar; 17(5):656-66. PubMed ID: 18024964 [TBL] [Abstract][Full Text] [Related]
31. Congenital hereditary endothelial dystrophy caused by SLC4A11 mutations progresses to Harboyan syndrome. Siddiqui S; Zenteno JC; Rice A; Chacón-Camacho O; Naylor SG; Rivera-de la Parra D; Spokes DM; James N; Toomes C; Inglehearn CF; Ali M Cornea; 2014 Mar; 33(3):247-51. PubMed ID: 24351571 [TBL] [Abstract][Full Text] [Related]
33. Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation. Alka K; Casey JR Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4258-4267. PubMed ID: 30140924 [TBL] [Abstract][Full Text] [Related]
34. High Throughput Assay Identifies Glafenine as a Corrector for the Folding Defect in Corneal Dystrophy-Causing Mutants of SLC4A11. Chiu AM; Mandziuk JJ; Loganathan SK; Alka K; Casey JR Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7739-53. PubMed ID: 26641551 [TBL] [Abstract][Full Text] [Related]
35. Localization of the gene for autosomal recessive congenital hereditary endothelial dystrophy (CHED2) to chromosome 20 by homozygosity mapping. Hand CK; Harmon DL; Kennedy SM; FitzSimon JS; Collum LM; Parfrey NA Genomics; 1999 Oct; 61(1):1-4. PubMed ID: 10512674 [TBL] [Abstract][Full Text] [Related]
36. Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy. Salman M; Verma A; Chaurasia S; Prasad D; Kannabiran C; Singh V; Ramappa M Orphanet J Rare Dis; 2022 Sep; 17(1):361. PubMed ID: 36115991 [TBL] [Abstract][Full Text] [Related]
37. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy. Riazuddin SA; Vithana EN; Seet LF; Liu Y; Al-Saif A; Koh LW; Heng YM; Aung T; Meadows DN; Eghrari AO; Gottsch JD; Katsanis N Hum Mutat; 2010 Nov; 31(11):1261-8. PubMed ID: 20848555 [TBL] [Abstract][Full Text] [Related]
38. SLC4A11 and the Pathophysiology of Congenital Hereditary Endothelial Dystrophy. Patel SP; Parker MD Biomed Res Int; 2015; 2015():475392. PubMed ID: 26451371 [TBL] [Abstract][Full Text] [Related]
39. Molecular phenotype of SLC4A11 missense mutants: Setting the stage for personalized medicine in corneal dystrophies. Alka K; Casey JR Hum Mutat; 2018 May; 39(5):676-690. PubMed ID: 29327391 [TBL] [Abstract][Full Text] [Related]
40. Detailed assessment of renal function in a proband with Harboyan syndrome caused by a novel homozygous SLC4A11 nonsense mutation. Liskova P; Dudakova L; Tesar V; Bednarova V; Kidorova J; Jirsova K; Davidson AE; Hardcastle AJ Ophthalmic Res; 2015; 53(1):30-5. PubMed ID: 25500497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]